140 related articles for article (PubMed ID: 15530990)
1. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
2. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
4. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.
Pouget C; Fagnere C; Basly JP; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2002 Oct; 12(20):2859-61. PubMed ID: 12270163
[TBL] [Abstract][Full Text] [Related]
6. Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
Gobbi S; Zimmer C; Belluti F; Rampa A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2010 Jul; 53(14):5347-51. PubMed ID: 20568782
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
J Med Chem; 2005 Oct; 48(20):6379-85. PubMed ID: 16190763
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.
Maiti A; Cuendet M; Croy VL; Endringer DC; Pezzuto JM; Cushman M
J Med Chem; 2007 Jun; 50(12):2799-806. PubMed ID: 17511439
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.
van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740
[TBL] [Abstract][Full Text] [Related]
11. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM
J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216
[TBL] [Abstract][Full Text] [Related]
12. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
ChemMedChem; 2007 Dec; 2(12):1750-62. PubMed ID: 17910019
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of azole isoflavone inhibitors of aromatase.
Hackett JC; Kim YW; Su B; Brueggemeier RW
Bioorg Med Chem; 2005 Jun; 13(12):4063-70. PubMed ID: 15911319
[TBL] [Abstract][Full Text] [Related]
14. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
15. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme.
Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors.
Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
Kim YW; Hackett JC; Brueggemeier RW
J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.
Wang R; Shi HF; Zhao JF; He YP; Zhang HB; Liu JP
Bioorg Med Chem Lett; 2013 Mar; 23(6):1760-2. PubMed ID: 23403081
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors.
Hida F; Robert J; Luu-Duc C
Farmaco; 1994; 49(7-8):489-92. PubMed ID: 7945714
[TBL] [Abstract][Full Text] [Related]
20. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV
J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
